Resveratrol analogue antioxidation 1387
[24] Fang JG, Zhou B. Structure-activity relationship and mecha-
nism of the tocopherol-regenerating activity of resveratrol
[38] Rubbo H, Radi R, Anselmi D, Kirk M, Barnes S, Butler J,
et al. Nitric oxide reaction with lipid peroxyl radicals spares
alpha-tocopherol during lipid peroxidation. Greater oxidant
protection from the pair nitric oxide/alpha-tocopherol than
and its analogues.
11458–11463.
J Agric Food Chem 2008;56(23):
[25] Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM,
Orlando RA, Deck LM, et al. Substituted trans-stilbenes,
including analogues of the natural product resveratrol, inhibit
the human tumor necrosis factor alpha-induced activation of
transcription factor nuclear factor kappaB. J Med Chem
2006;49(24):7182–7189.
alpha-tocopherol/ascorbate.
10812–10818.
[39] YangY, Song ZG, Liu ZQ. Synthesis and antioxidant capaci-
ties of hydroxyl derivatives of cinnamoylphenethylamine in
protecting DNA and scavenging radicals. Free Radic Res
2011;45(4):445–453.
J Biol Chem 2000;275(15):
[26] Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL, Wyche JH, et al.
The 3,4-dihydroxyl groups are important for trans-resveratrol
analogs to exhibit enhanced antioxidant and apoptotic activi-
ties. Anticancer Res 2004;24(2B):999–1002.
[27] Shang YJ, Qian Y, Liu XD, Dai F, Shang XL, Jia WQ, et al.
Radical-scavenging activity and mechanism of resveratrol-
oriented analogues: influence of the solvent, radical, and sub-
stitution. J Org Chem 2009;74(14):5025–5031.
[28] Roberti M, Pizzirani D, Simoni D, Rondanin R, Baruchello
R, Bonora C, et al. Synthesis and biological evaluation of
resveratrol and analogues as apoptosis-inducing agents. J Med
Chem 2003;46(16):3546–3554.
[29] Mazue F, Colin D, Gobbo J,Wegner M, Rescifina A, Spatafora
C, et al. Structural determinants of resveratrol for cell prolif-
eration inhibition potency: experimental and docking studies
of new analogs. Eur J Med Chem 2010;45(7):2972–2980.
[30] de Lima DP, Rotta R, Beatriz A, Marques MR, Montenegro
RC, Vasconcellos MC, et al. Synthesis and biological evalua-
tion of cytotoxic properties of stilbene-based resveratrol ana-
logs. Eur J Med Chem 2009;44(2):701–707.
[40] Piette J. Biological consequences associated with DNA oxida-
tion mediated by singlet oxygen. J Photochem Photobiol B
1991;11(3–4):241–260.
[41] Iglesias J, Pazos M, Andersen ML, Skibsted LH, Medina I.
Caffeic acid as antioxidant in fish muscle: mechanism of syn-
ergism with endogenous ascorbic acid and alpha-tocopherol.
J Agric Food Chem 2009;57(2):675–681.
[42] Niki E. Interaction of ascorbate and alpha-tocopherol. Ann N
Y Acad Sci 1987;498:186–199.
[43] Frombaum M, Therond P, Djelidi R, Beaudeux JL,
Bonnefont-Rousselot D, Borderie D. Piceatannol is more
effective than resveratrol in restoring endothelial cell dimeth-
ylarginine dimethylaminohydrolase expression and activity
after high-glucose oxidative stress. Free Radic Res 2011;45
(3):293–302.
[44] Hung LM, Chen JK, Lee RS, Liang HC, Su MJ. Beneficial
effects of astringinin, a resveratrol analogue, on the ischemia
and reperfusion damage in rat heart. Free Radic Biol Med
2001;30(8):877–883.
[45] Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient
biological carotenoid singlet oxygen quencher. Arch Biochem
Biophys 1989;274(2):532–538.
[31] YamamotoY, Niki E, KamiyaY, Miki M, Tamai H, Mino M.
Free radical chain oxidation and hemolysis of erythrocytes by
molecular oxygen and their inhibition by vitamin E. J Nutr
Sci Vitaminol (Tokyo) 1986;32(5):475–479.
[32] Fang JG, Lu M, Ma LP,Yang L, Wu LM, Liu ZL. Protective
effects of resveratrol and its analogues against free radical-
induced oxidative hemolysis of red blood cells. Chinese
Journal of Chemistry 2002;20(11):1313–1318.
[46] Foote CS, Denny RW. Chemistry of singlet oxygen. VII.
Quenching by beta-carotene.
90(22):6233–6235.
J Am Chem Soc 1968;
[47] Celaje JA, Zhang D, Guerrero AM, Selke M. Chemistry of
trans-Resveratrol with Singlet Oxygen: [2 ϩ 2] Addition,
[4 ϩ 2] Addition, and Formation of the Phytoalexin Moracin
M. Org Lett 2011;13(18):4846–4849.
[48] Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O.
Resveratrol, a remarkable inhibitor of ribonucleotide reduct-
ase. FEBS Lett 1998;421(3):277–279.
[49] Holmgren A, Sengupta R.The use of thiols by ribonucleotide
reductase. Free Radic Biol Med 2010;49(11):1617–1628.
[50] Fritzer-Szekeres M, Savinc I, Horvath Z, Saiko P, Pemberger
M, Graser G, et al. Biochemical effects of piceatannol in
human HL-60 promyelocytic leukemia cells—synergism with
Ara-C. Int J Oncol 2008;33(4):887–892.
[51] Saiko P, Pemberger M, Horvath Z, Savinc I, Grusch M,
Handler N, et al. Novel resveratrol analogs induce apoptosis
and cause cell cycle arrest in HT29 human colon cancer cells:
inhibition of ribonucleotide reductase activity. Oncol Rep
2008;19(6):1621–1626.
[33] Epe B, Pflaum M, Boiteux S. DNA damage induced by pho-
tosensitizers in cellular and cell-free systems. Mutat Res
1993;299(3–4):135–145.
[34] Kumar SS, Ghosh A, Devasagayam TP, Chauhan PS. Effect of
vanillin on methylene blue plus light-induced single-strand breaks
in plasmid pBR322 DNA. Mutat Res 2000;469(2):207–214.
[35] Porter NA, Caldwell SE, Mills KA. Mechanisms of free radical
oxidation of unsaturated lipids. Lipids 1995;30(4):277–290.
[36] Goupy P,Vulcain E, Caris-Veyrat C, Dangles O. Dietary anti-
oxidants as inhibitors of the heme-induced peroxidation of
linoleic acid: mechanism of action and synergism. Free Radic
Biol Med 2007;43(6):933–946.
[37] Chao CC, MaYS, Stadtman ER. Modification of protein sur-
face hydrophobicity and methionine oxidation by oxidative
systems. Proc Natl Acad Sci U S A 1997;94(7):2969–2974.
This paper was first published online on Early Online on
28 October 2011.